Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
chlorambucil, tablets
ofatumumab (GSK1841157) infusion
Locations
6
Japan
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Hokkaido, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Kyoto, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
Start Date
April 1, 2012
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
August 10, 2015
NCT00824265
NCT00742144
NCT01077622
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions